According to the American Cancer Society, about 1 out of every 8 men will be diagnosed with prostate cancer during his lifetime...
Optina Diagnostics' pioneering pivotal REPHRASE study, currently underway, is poised to revolutionize the diagnosis and management of Alzheimer's Disease (AD). This landmark study is focused on validating the novel awAIr™-Cerebral Amyloid Status (CAS) test, an innovative tool intended to provide physicians with definitive information about Alzheimer's pathology, enabling improved management of cognitive impairments....
Patient-Led Global Summit on Science, Policy, and Care Choice Drives Optimism...
OncoBindTM IDE Approved to Study Metastatic Cancer...
hrough this partnership, Strive Health, Prominence Health Plan and Sierra Nevada Specialty Care will bring high-quality care to patients with kidney disease across Nevada...
Leading Global Skincare Brand Reinforces Commitment to Menopausal Skincare by Joining Forces with Innovative Wellness Technology to Empower Women During the Menopause Transition...
First pre-sutured fascia allograft designed for hip arthroscopists to help increase surgeon efficiency and reduce operating room time...
Skanska has signed a contract amendment with Oregon Health & Science University for its Hospital Expansion Project in Portland, Oregon, USA. The contract amendment is worth USD 91M, about SEK 1.0 billion, which will be included in the US order bookings for the second quarter of 2023....
Getinge announces clearance from the US FDA for Servo-air® Lite, a wall gas independent non-invasive mechanical ventilator....
Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the AVEIR™ dual chamber (DR) leadless pacemaker system, the world's first dual chamber leadless pacing system that treats people with abnormal or slow heart rhythms. With more than 80% of people who need a pacemaker requiring pacing in two chambers of the heart (both the right atrium and right ventricle), the approval significantly increases access to leadless pacing for millions of people across the U.S.[i]...
